Kovacs M J, Anderson D A, Wells P S
Department of Medicine, London Health Sciences Centre, London, Ontario, Canada.
Pathophysiol Haemost Thromb. 2002 May-Jun;32(3):131-3. doi: 10.1159/000065215.
Venous thromboembolism is a common medical problem. Recently, the emphasis has been on a switch to outpatient low molecular weight heparin therapy. Previous warfarin nomograms have been developed only for inpatients. We prospectively assessed a warfarin initiation nomogram in 105 consecutive outpatients; the nomogram requires International Normalized Ratio (INR) testing on only days 3, 5, and 8. Eighty-three percent had a therapeutic INR by day 5 and 98% by day 8. There were no major bleeds and only 6 instances of INR >4.5. This outpatient warfarin nomogram appears to be safe and efficacious in obtaining timely therapeutic levels of warfarin and deserves further study.
静脉血栓栓塞是一个常见的医学问题。最近,重点已转向改用门诊低分子量肝素治疗。以前的华法林剂量表仅针对住院患者制定。我们前瞻性地评估了105例连续门诊患者的华法林起始剂量表;该剂量表仅要求在第3、5和8天进行国际标准化比值(INR)检测。83%的患者在第5天达到治疗性INR,98%的患者在第8天达到。没有发生大出血,INR>4.5的情况仅出现6次。这种门诊华法林剂量表在及时获得华法林治疗水平方面似乎是安全有效的,值得进一步研究。